Disparities in treatment rates of paediatric end-stage renal disease across Europe: Insights from the ESPN/ERA-EDTA registry

Nicholas C. Chesnaye, Franz Schaefer, Jaap W. Groothoff, Fergus J. Caskey, James G. Heaf, Stella Kushnirenko, Malcolm Lewis, Reiner Mauel, Elisabeth Maurer, Jussi Merenmies, Diamant Shtiza, Rezan Topaloglu, Natalia Zaicova, Argyroula Zampetoglou, Kitty J. Jager, Karlijn J. Van Stralen*

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review


    BackgroundConsiderable disparities exist in the provision of paediatric renal replacement therapy (RRT) across Europe. This study aims to determine whether these disparities arise from geographical differences in the occurrence of renal disease, or whether country-level access-to-care factors may be responsible. MethodsIncidence was defined as the number of new patients aged 0-14 years starting RRT per year, between 2007 and 2011, per million children (pmc), and was extracted from the ESPN/ERA-EDTA registry database for 35 European countries. Country-level indicators on macroeconomics, perinatal care and physical access to treatment were collected through an online survey and from the World Bank database. The estimated effect is presented per 1SD increase for each indicator. ResultsThe incidence of paediatric RRT in Europe was 5.4 cases pmc. Incidence decreased from Western to Eastern Europe (-1.91 pmc/1321 km, P < 0.0001), and increased from Southern to Northern Europe (0.93 pmc/838 km, P = 0.002). Regional differences in the occurrence of specific renal diseases were marginal. Higher RRT treatment rates were found in wealthier countries (2.47 pmc/€10 378 GDP per capita, P < 0.0001), among those that tend to spend more on healthcare (1.45 pmc/1.7% public health expenditure, P < 0.0001), and among countries where patients pay less out-of-pocket for healthcare (-1.29 pmc/11.7% out-of-pocket health expenditure, P < 0.0001). Country neonatal mortality was inversely related with incidence in the youngest patients (ages 0-4, -1.1 pmc/2.1 deaths per 1000 births, P = 0.10). Countries with a higher incidence had a lower average age at RRT start, which was fully explained by country GDP per capita. ConclusionsInequalities exist in the provision of paediatric RRT throughout Europe, most of which are explained by differences in country macroeconomics, which limit the provision of treatment particularly in the youngest patients. This poses a challenge for healthcare policy makers in their aim to ensure universal and equal access to high-quality healthcare services across Europe.

    Sider (fra-til)1377-1385
    Antal sider9
    TidsskriftNephrology Dialysis Transplantation
    Udgave nummer8
    StatusUdgivet - 1 aug. 2015


    Udforsk hvilke forskningsemner 'Disparities in treatment rates of paediatric end-stage renal disease across Europe: Insights from the ESPN/ERA-EDTA registry' indeholder.